{"id":"NCT00609466","sponsor":"Gr√ºnenthal GmbH","briefTitle":"A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy","officialTitle":"A Randomized, Double-blind, Parallel-group, Multi-center, Active- and Placebo-controlled Trial to Evaluate the Analgesic Efficacy and Safety of Multiple Doses of CG5503 IR for Postoperative Pain Following Bunionectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2008-02-07","resultsPosted":"2009-11-25","lastUpdate":"2011-11-16"},"enrollment":291,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bunionectomy","Pain","Postoperative Pain","Acute Pain"],"interventions":[{"type":"DRUG","name":"CG5503 IR","otherNames":[]},{"type":"DRUG","name":"Morphine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"The main objective of this trial is to demonstrate the efficacy and safety of multiple-dose application of oral application of CG5503 IR 75mg compared to placebo and to assess safety and tolerability of CG5503 IR 75mg in subjects following bunionectomy.\n\nThis trial was performed based on a previously performed double-blind, placebo-controlled, multiple-dose trial in the same indication investigating 3 dose strengths CG5503 IR (50, 75 and 100 mg) published under PMID: 18851776.","primaryOutcome":{"measure":"Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity.","timeFrame":"Baseline value to 48 hours after first study drug intake.","effectByArm":[{"arm":"CG5503","deltaMin":46.2,"sd":130.83},{"arm":"Morphine","deltaMin":102.5,"sd":153.26},{"arm":"Placebo","deltaMin":-17.5,"sd":111.27}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Nausea","Vomiting","Headache","Dizziness","Pruritus"]}}